Furosemide, the prevention of epistaxis and related considerations: A preliminary evaluation

Thomas Tobin, Richard H. Galley, Kimberly Brewer, Abelardo Morales Briceño, Diana Villoria Leon

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Furosemide is widely approved in the United States, Canada and elsewhere in the Americas for the prevention of Exercise Induced Pulmonary Hemorrhage [EIPH]. We review the scientific evidence for the efficacy of furosemide in reduction/ prevention of EIPH, including, presumably, EIPH related acute/sudden death in racing horses. We present evidence from the scientific literature and our own experience, clinical and otherwise [RHG, AMB, DVL, and TT], that EIPH driven acute/sudden death in racing horses has significant adverse health consequences for horses and jockeys. We then outline the adverse effects on equine and human [jockey] health and welfare to be expected when furosemide is not approved for use in racing horses or, where approved, if approval is withdrawn.

Original languageEnglish
Pages (from-to)176-185
Number of pages10
JournalInternational Journal of Applied Research in Veterinary Medicine
Issue number2
StatePublished - 2010


  • Cute/sudden death
  • Epistaxis
  • Exercise induced pulmonary hemorrhage [EIPH]
  • Furosemide
  • Horses
  • Jockeys
  • Regulatory approval
  • United states

ASJC Scopus subject areas

  • General Veterinary


Dive into the research topics of 'Furosemide, the prevention of epistaxis and related considerations: A preliminary evaluation'. Together they form a unique fingerprint.

Cite this